Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
06/2003
06/04/2003EP1315728A1 Process for the preparation of vitronectin receptor antagonists
06/04/2003EP1315726A1 7- oxo pyridopyrimidines as inhibitors of cellular proliferation
06/04/2003EP1315719A1 Multivalent neuraminidase inhibitor conjugates
06/04/2003EP1315718A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315715A1 Quinazoline derivatives as kinase inhibitors
06/04/2003EP1315714A2 Quinazoline derivatives as alpha-1 adrenergic antagonists
06/04/2003EP1315705A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
06/04/2003EP1315704A1 2-guanidino-4-aryl-quinazoline
06/04/2003EP1315698A1 Pyrrolidines as inhibitors of neuraminidases
06/04/2003EP1315691A1 Method of obtaining a hydroxytyrosol-rich composition from vegetation water
06/04/2003EP1315539A2 Antithrombotic compositions
06/04/2003EP1315517A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same
06/04/2003EP1315514A2 Methods and compositions for producing a neurosalutary effect in a subject
06/04/2003EP1315513A2 "pseudo"-native chemical ligation
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP1315511A2 Synthetic erythropoiesis stimulating proteins
06/04/2003EP1315509A2 Treatment of drug resistant organisms with nitric oxide
06/04/2003EP1315502A1 Method for treating erectile dysfunction and increasing libido in men
06/04/2003EP1315501A1 Alpha v integrin receptor antagonists
06/04/2003EP1315500A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
06/04/2003EP1315495A2 Use of threo-methylphenidate compounds to enhance memory
06/04/2003EP1315494A1 Agent for modulating excitatory synaptic transmission comprising a compound having alpha-7 nicotinic acetylcholine receptor activation property
06/04/2003EP1315493A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
06/04/2003EP1315492A2 A method for treating allergies using substituted pyrazoles
06/04/2003EP1315490A2 A method for treating allergies using substituted pyrazoles
06/04/2003EP1315486A2 Antitumor combination comprising an aromatase inhibitor and an egfr antagonist or inhibitor
06/04/2003EP1315483A2 Combined estrogen blockade of the breast with exemestane and raloxifene
06/04/2003EP1315475A1 Lung surfactant compositions with dynamic swelling behaviour
06/04/2003EP1252150B1 Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
06/04/2003EP1214347B1 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs
06/04/2003EP1200099B1 Synergistic composition comprising daunorubicin derivatives and antimetabolite compounds
06/04/2003EP1140186B1 Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
06/04/2003EP1121121B1 Methods for inhibiting diabetic complications
06/04/2003EP1095007B1 Water-soluble zinc pyruvates or their hydrates, method for the production thereof and their use
06/04/2003EP1075476B1 Novel benzimidazoles and benzoxazoles
06/04/2003EP1038863B1 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
06/04/2003EP0980244B1 Use of quinazoline compounds for the treatment of polycystic kidney disease
06/04/2003EP0973790B1 Estra-5(10),7-dienes with estrogenic activity
06/04/2003EP0970084B1 Pyrrolo 2,3d]pyrimidines and their use as tyrosine kinase inhibitors
06/04/2003EP0968180B1 Substituted derivatives of benzosulphonamides as inhibitors of the enzyme cyclooxygenase ii
06/04/2003EP0967987B1 Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents
06/04/2003EP0944616B1 Bicyclic aryl carboxamides and their therapeutic use
06/04/2003EP0909175B1 Non-aqueous protic peptide formulations
06/04/2003EP0901487B1 2,3,6 trisubstituted-4(3h)-quinazolinones
06/04/2003EP0882023B1 Histamine h 3 receptor ligands
06/04/2003EP0820452B1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase
06/04/2003EP0819120B1 Tricyclic compounds useful for inhibition of farnesyl protein transferase
06/04/2003EP0817641B1 Substances extracted from dictyotales, preparation method therefor, and compositions containing same
06/04/2003EP0789578B1 Multicatalytic protease inhibitors
06/04/2003EP0783507B1 Compounds useful as antiproliferative agents and garft inhibitors
06/04/2003EP0775135B1 N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics
06/04/2003EP0775120B1 Novel pyrimidine derivatives and processes for the preparation thereof
06/04/2003EP0775118B1 Benzimidazole derivatives having dopaminergic activity
06/04/2003EP0773940B1 Process for synthesis of substituted sulphoxides
06/04/2003EP0670730B1 Fusion protein comprising two tumor necrosis factor receptors
06/04/2003EP0665752B1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
06/04/2003EP0606366B1 Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase
06/04/2003CN1422271A Pyrrolopyrimidinone derivatives, process of preparation and use
06/04/2003CN1422269A 1H-imidazopyridine derivatives
06/04/2003CN1422268A 5-alkylpyrido [2,3-D] pyrimidines tyrosine kinase inhibitors
06/04/2003CN1422263A Estrogen agonist/antagonist metabolites
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422260A 2-guanidino-4-arylchinazolines as NHE-3 inhibitors
06/04/2003CN1422259A Crystalline pharmaceutical
06/04/2003CN1422253A Carbamate caspase inhibitors and uses thereof
06/04/2003CN1422252A Chemokine receptor antagonists
06/04/2003CN1422245A Method for synthesis of N-[(S)-1-carboxybutyl]-(S)-alanine esters and use in synthesis of perindopril
06/04/2003CN1422161A New combination of a beta blocker and a cholesterol-lowering agent
06/04/2003CN1422159A Remedies
06/04/2003CN1422155A Urease inhibitors
06/04/2003CN1422154A The treatment of respiratory diseases
06/04/2003CN1422153A Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
06/04/2003CN1422151A Pharmaceutical composition comprising fluvastatin
06/04/2003CN1422146A Use of alcohol dehydrogenase inhibitors for cosmetic treatment of keratinous materials
06/04/2003CN1421456A Human apolipoprotein polypeptide and its use in resisting vascular proliferation diseases
06/04/2003CN1421243A New use of medicine for preventing and treating radiative damage
06/04/2003CN1421227A Medicine for preventing and treating radiative damage
06/04/2003CN1421212A Cell growth regulating factor J and its prepn process
06/04/2003CN1421211A Cell growth regulating factor M and its prepn process
06/04/2003CN1421210A Cell growth regulating factor P and its prepn process
06/04/2003CN1421209A Ribose oral liquid
06/04/2003CN1421197A Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
06/04/2003CN1421196A Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
06/04/2003CN1421195A Composition containing N-vinyl iminazole polymer of copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
06/04/2003CN1421194A Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
06/04/2003CN1421193A Composition containing N-vinyl iminazole polymer or copolymer and oxidation sensitive hydrophilic active ingredients for cosmetics and/or dermatology
06/04/2003CN1110558C Novel growth/differentiation factor of the TGF-ÔÇÿbetaÔÇÖfamily
06/04/2003CN1110498C Triazolo-pyridzine derivatives as ligands for GABA receptors
06/04/2003CN1110497C Di-or triaza-spiral [4,5] decane derivative
06/04/2003CN1110495C Arylalkyl diazinones, its preparing method and its medical preparation
06/04/2003CN1110494C Novel active benzothiepines having inhibitors forileal bile acid transfer and taurocholate salt adsorption
06/04/2003CN1110493C Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors
06/04/2003CN1110492C Prodrugs of aspartyl protease inhibitors
06/04/2003CN1110491C Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
06/04/2003CN1110484C 2-(cary lphenyl) amino-imidazoline derivatives
06/04/2003CN1110482C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
06/04/2003CN1110317C Production process of salt algae powder and its soft capsule
06/04/2003CN1110312C Medicine with wild cottonrose hibiscus
06/04/2003CN1110311C Wild cottonrose hibiscus bud product
06/03/2003US6573362 Of given amino acid sequence; binding inhibition; can use in reducing or influencing inflammations, improving wound healing, suppressing theimmune system for organ transplants, preventing metastasis of tumors and treating arteriosclerosis
1 ... 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 ... 1564